
HNGE Stock Forecast & Price Target
HNGE Analyst Ratings
Bulls say
Hinge Health Inc has demonstrated significant financial growth, with last twelve months (LTM) calculated billings increasing nearly 44% year-over-year to $671 million and a client count rising by 25% to over 2,800, indicating strong market demand and retention. The company reported revenue of $170.7 million, reflecting a 46% year-over-year increase, which surpassed both consensus estimates and prior predictions, highlighting its robust operational performance. Looking forward, Hinge Health's guidance for 2026 suggests further expansion potential, projecting revenue growth that outpaces analyst expectations, reinforcing a positive outlook on its market position and financial health.
Bears say
The analysis of Hinge Health Inc indicates concerns over its future performance, primarily linked to a projected macro-driven weak spending environment in the second half of 2025, which may lead to slower than anticipated growth in fiscal year 2026. While the company has shown strong non-GAAP gross and operating margins compared to consensus estimates, the prevailing economic conditions could hinder its ability to maintain revenue growth, particularly due to its reliance on employee utilization for billings. Additionally, competition dynamics suggest that budget constraints are causing potential clients to delay decisions, posing a significant risk to Hinge Health's revenue generation in the upcoming periods.
This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.
HNGE Analyst Forecast & Price Prediction
Start investing in HNGE
Order type
Buy in
Order amount
Est. shares
0 shares